About Mediwhale
Mediwhale is an AI-powered healthcare company dedicated to developing preventive technologies that enable personalized disease management and early risk detection of major chronic diseases. The company leverages retinal imaging and artificial intelligence to establish a new standard in early detection, personalized risk assessment, and preventive care for cardiometabolic diseases. Their core mission is to empower everyone to detect health risks early through a simple eye scan in primary care settings, making this approach easy, accessible, safe, and cost-effective. Mediwhale's flagship product, Dr. Noon CVD, is the world's first regulatory-approved AI solution for cardiovascular risk assessment using retinal imaging, demonstrating predictive accuracy comparable to heart CT scans. Dr. Noon Fundus diagnoses retinal abnormalities including glaucoma, cataracts, and retinal diseases from a single retinal photograph. Built on over 2.1 million high-quality clinical data points and validated through 50+ peer-reviewed publications, Mediwhale's AI is trained across diverse populations and imaging devices. The company's solutions are commercially deployed beyond pilot stage, certified in 8 regions, and adopted by hospitals and clinics worldwide in Korea, Dubai, the UK, and Italy. Mediwhale's technology provides safe, radiation-free tests completed in minutes, offering instant, accurate results for doctors while ensuring maximum patient comfort.
Mission & Story
Mission
We believe that early detection is key to prevention. Our mission is to empower everyone to detect health risks early through a simple eye scan in a primary care setting, making this approach easy, accessible, safe, and cost-effective.
Clinical Focus
Medical conditions and clinical areas addressed by Mediwhale.
Who It Serves
Milestones & Awards
Recent Milestones
EU CE MDR approval (May 2025), Series C funding of ₩20 billion preparing for IPO (March 2025), MICCAI 2024 1st place winner in two diabetic retinopathy categories
Awards & Recognition
2025 Digital Health Awards Rising Star Finalist for AI in Patient Care, NextRise Award 2025 Top Innovator, Digital Health Startups Top 50 (2024), 2024 Digital Health Awards Quarterfinalists, MICCAI 2024 1st place (2 categories), E-nnova Health 2023 Awards Winner, AstraZeneca CKD Challenge 1st Place, MICCAI 2023 3rd place, 2023 CES Innovation Awards
Key Partnerships
Social & Media
Follow on
Latest Updates
Company Details
- Headquarters
- Seoul, Gangnam District, South Korea
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.